Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1

Cited by (660)

Items 301–400 of 660

1. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer
   Yibao Ma, C Yu, Esraa Mohamed, Huanjie Shao, L Wang, G Sundaresan, Jamal Zweit, Michael O. Idowu, Xianjun Fang · 2016 · Oncogene
2. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia‐inducible factor‐1 in human hepatoma HepG2 cells
   Qinsheng Dai, Qian Yin, Libin Wei, Yuxin Zhou, Chen Qiao, Yongjian Guo, Xuemin Wang, Shiping Ma, Na Lu · 2015 · Molecular Carcinogenesis
3. The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
   Lauren C.J. Baker, Jessica K.R. Boult, Simon Walker‐Samuel, Y-L Chung, Yann Jamin, Margaret A. Ashcroft, Simon P. Robinson · 2012 · British Journal of Cancer
4. The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
   Sarbajeet Nagdas, David F. Kashatus · 2017 · Antioxidants
5. Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression
   Zhenqian Wu, Xiaodong Han, Gewen Tan, Qingchao Zhu, Hongqi Chen, Yang Xia, Jianfeng Gong, Zhigang Wang, Yu Wang, Jun Yan · 2020 · OncoTargets and Therapy
6. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma
   Hyun Gyu Lee, Hyemi Kim, Taekwon Son, Youngtae Jeong, Seung Up Kim, Seung Myung Dong, Young Nyun Park, Jong Doo Lee, Jae Myun Lee, Jeon Han Park · 2016 · Oncotarget
7. Alteration of cellular metabolism in cancer cells and its therapeutic prospects
   Biranchi Narayan Biswal, SuryaNarayan Das, BijoyKumar Das, Rachna Rath · 2017 · Journal of Oral and Maxillofacial Pathology
8. Potential roles of IL-1 subfamily members in glycolysis in disease
   Qi Tan, Qi Huang, Ling Yan, Kaimin Mao, Guanghai Yang, Ping Luo, Guanzhou Ma, Peiyuan Mei, Yang Jin · 2018 · Cytokine & Growth Factor Reviews
9. The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder
   Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallée · 2020 · Translational Psychiatry
10. Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities
    John P. Harrelson, Michael W. Lee · 2016 · Pharmacology & Therapeutics
11. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
    Cristina Trejo‐Solís, Rosa Angélica Castillo‐Rodríguez, Norma Serrano-García, Daniela Silva‐Adaya, Salvador Vargas-Cruz, Elda Georgina Chávez-Cortéz, Juan Carlos Gallardo‐Pérez, Sergio Zavala-Vega, Arturo Cruz-Salgado, Roxana Magaña-Maldonado · 2024 · Metabolites
12. Hypoxia sensing through β-adrenergic receptors
    Hoi I. Cheong, Kewal Asosingh, Olivia R. Stephens, Kimberly A. Queisser, Weiling Xu, Belinda B. Willard, Bo Hu, Josephine Kam Tai Dermawan, George Robert Stark, Sathyamangla V Naga Prasad et al. · 2016 · JCI Insight
13. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration
    Carmen Rodrı́guez, Noelia Puente‐Moncada, Russel Joseph Reiter, Ana M. Sánchez‐Sánchez, Federico Herrera, Jezabel Rodríguez‐Blanco, Cristina Duarte‐Olivenza, María Turos‐Cabal, Isaac Antolı́n, Vanesa Martı́n · 2020 · Journal of Cellular Physiology
14. Molecular basis and clinical implications of HIFs in cardiovascular diseases
    Yiqing Hu, Hao Lu, Hua Li, Junbo Ge · 2022 · Trends in Molecular Medicine
15. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)
    Daniel Baumunk, Uta Reichelt, Jannis Hildebrandt, Hans Krause, Jan Ebbing, Hannes Cash, Kurt Miller, Martin Schostak, Steffen Weikert · 2012 · World Journal of Urology
16. Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies
    Sana Ahuja, Sufian Zaheer · 2025 · Immunology
17. Hypoxia-induced IL-32β increases glycolysis in breast cancer cells
    Jeong Su Park, Sunyi Lee, Ae Lee Jeong, Sora Han, Hye In Ka, Jong‐Seok Lim, Myung Sok Lee, Do‐Young Yoon, Jeong‐Hyung Lee, Young Yang · 2014 · Cancer Letters
18. siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells
    Matthew T. Menendez, Crystal Teygong, Kristin R. Wade, Célia Florimond, Ira J. Blader · 2015 · mBio
19. The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity
    Nataly Tarasenko, Gania Kessler‐Icekson, Pnina Boer, Aida Inbal, Hadassa Schlesinger, Don R. Phillips, Suzanne M. Cutts, Abraham Nudelman, Ada Rephaeli · 2010 · Investigational New Drugs
20. Targeting MYC at the intersection between cancer metabolism and oncoimmunology
    Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, Jarek Meller, Rutaiwan Tohtong, Somchai Chutipongtanate · 2024 · Frontiers in Immunology
21. Dual oxidase 2 and pancreatic adenocarcinoma: IFN-γ-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1α and VEGF-A
    Yongzhong Wu, Jennifer L. Meitzler, Smitha Antony, Agnes N. Juhasz, Jiamo Lu, Guojian Jiang, Han Liu, Melinda G. Hollingshead, Diana C. Haines, Donna O. Butcher et al. · 2016 · Oncotarget
22. Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1α
    Yue‐Zhi Lee, Huan-Chen Guo, Guan-Hao Zhao, Cheng‐Wei Yang, Hsin-Yu Chang, Ruey‐Bing Yang, Linyi Chen, Shiow‐Ju Lee · 2019 · Pharmacological Research
23. Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer
    Patrícia L. Abreu, Leonardo M. R. Ferreira, Maria Carmen Alpoim, Ana M. Urbano · 2014 · BioMetals
24. Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
    Yves Lecarpentier, E Gourrier, Vincent Gobert, Alexandre Vallée · 2019 · Frontiers in Pediatrics
25. Energy sources identify metabolic phenotypes in pancreatic cancer
    Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu et al. · 2016 · Acta Biochimica et Biophysica Sinica
26. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review)
    Mingzhe Li, Xin Bu, Bolei Cai, Ping Liang, Kai Li, Xuan Qu, Liangliang Shen · 2018 · Oncology Reports
27. Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
    Mélody Caillot, Jérôme Bourgeais, Hassan Dakik, Élodie Costé, Nathalie M. Mazure, Eric Lelièvre, Olivier Coqueret, Olivier Hérault, Frédéric Mazurier, Brigitte Sola · 2020 · Oncogenesis
28. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer
    Yu Fan Zhang, Zhi Hong Zhang, Ming Yue Li, Jing Ying Wang, Yue Xing, MyongHak Ri, Cheng Hua Jin, Guang Hua Xu, Lian Xun Piao, Hong Xiang Zuo et al. · 2020 · Phytomedicine
29. Regulation of humoral immune response by HIF-1α-dependent metabolic reprogramming of the germinal center reaction
    Lingyun Li, Chunlei Feng, Jun Qin, Dali Li, Mingyao Liu, Shuhua Han, Biao Q Zheng · 2021 · Cellular Immunology
30. Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
    Sho Ikeda, Hiroyuki Tagawa · 2021 · Cancer Science
31. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?
    Yanxiang Cheng, Gantao Chen, Li Hong, Limei Zhou, Min Hu, Bingshu Li, Jinling Huang, Liangbin Xia, Cuilan Li · 2013 · Annals of Diagnostic Pathology
32. Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha
    Avinash D Sahu, Xiaoman Wang, Phillip B. Munson, Jan P.G. Klomp, Xiaoqing Wang, Shengqing Stan Gu, Gege Qian, Phillip Nicol, Zexian Zeng, Chenfei Wang et al. · 2023 · Cancer Discovery
33. Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential
    Shujie Liu, Xingzhu Liu, Xin Lin, Hongping Chen · 2023 · Cells
34. Molecular Pathways: Regulation of Metabolism by RB
    Brian F. Clem, Jason Alan Chesney · 2012 · Clinical Cancer Research
35. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma
    Kei Nakajima, Ichiro Kawashima, Megumi Koshiishi, Takuma Kumagai, Megumi Suzuki, Jun Suzuki, Toru Mitsumori, Keita Kirito · 2019 · Experimental Hematology
36. Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis
    Venkadesaperumal Gopu, Liang Fan, Rashmi R Shetty, M.R. Nagaraja, Sreerama Shetty · 2020 · JCI Insight
37. PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy
    Arezki Chekaoui, Hildegund C.J. Ertl · 2021 · Cancer Research
38. Inhibition of AMPK and Krebs Cycle Gene Expression Drives Metabolic Remodeling of Pten -Deficient Preneoplastic Thyroid Cells
    Valeria G. Antico Arciuch, Marika A. Russo, Kristy S. Kang, Antonio Di Cristofano · 2013 · Cancer Research
39. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer
    Gaochuan Zhang, Ping Yang, Peng-Da Guo, Lucio Miele, Fazlul H. Sarkar, Zhiwei Peter Wang, Quansheng Zhou · 2013 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
40. Systems-Scale Analysis Reveals Pathways Involved in Cellular Response to Methamphetamine
    Lijie Sun, Hongmei Li‐Byarlay, Manfredo J. Seufferheld, Kent R. Walters, Venu Madhav Margam, Amber Jannasch, Naomi Diaz, Catherine P. Riley, Weilin Sun, Yueh Feng Li et al. · 2011 · PLoS ONE
41. miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming
    Aliaa A. Alamoudi, Amina Alnoury, Hoda Gad · 2017 · Briefings in Functional Genomics
42. The Mechanisms of Regulation of Aerobic Glycolysis (Warburg Effect) by Oncoproteins in Carcinogenesis
    V. A. Kobliakov · 2019 · Biochemistry (Moscow)
43. Cancer cell metabolism regulates extracellular matrix degradation by invadopodia
    Remco van Horssen, Roberto Buccione, Marieke P. Willemse, Şahika Cıngır Köker, Bé Wieringa, Francesca Attanasio · 2013 · European Journal of Cell Biology
44. Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
    Tatsuyuki Chiyoda, Peter C. Hart, Mark A. Eckert, Stephanie M. McGregor, Ricardo R. Lastra, Ryuji Hamamoto, Yusuke Nakamura, S. Diane Yamada, Olufunmilayo Ibironke Olopade, Ernst R. Lengyel et al. · 2017 · Cancer Prevention Research
45. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment
    Jean‐François Dumas, Lucie Brisson, Stéphan Chevalier, Karine Mahéo, Gaëlle Fromont, Driffa Moussata, Pierre Besson, Sébastien Roger · 2017 · Seminars in Cancer Biology
46. ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
    Hao Geng, Brooks L. S. Rademacher, Janét Pittsenbarger, Chung-Ying Huang, Christopher T. Harvey, Marie C. Lafortune, Anne Myrthue, Mark G. Garzotto, Peter S. Nelson, Tomasz M. Beer et al. · 2010 · Cancer Research
47. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
    Vaishali Chandel, Sibi Raj, Prabhat Kumar, Shilpi Gupta, Anupam Dhasmana, Kavindra Kumar Kesari, Janne Ruokolainen, Pravesh Mehra, Bhudev Chandra Das, Mohammad Amjad Kamal et al. · 2020 · Life Sciences
48. Circular RNAs: Emerging regulators of glucose metabolism in cancer
    Zerong Cai, Yan Hu, Kun Lun Liao, Hao Ran Li, Dongliang Chen, Huai‐Qiang Ju · 2022 · Cancer Letters
49. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
    Zhao Deng, Des Raymond Richardson · 2023 · Pharmacological Reviews
50. Clinical development of cancer therapeutics that target metabolism
    Brian F. Clem, Julie O’Neal, Alden C. Klarer, S. Telang, Jason Alan Chesney · 2015 · QJM
51. Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway
    Alexandre Vallée, Yves Lecarpentier, Rodolphe Vallée, Rémy Guillevin, Jean-Noël Vallée · 2020 · International Journal of Molecular Sciences
52. Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
    Timon A. Bloedjes, Guus de Wilde, Jeroen E. J. Guikema · 2021 · Cancers
53. c-MYC inhibition impairs hypoxia response in glioblastoma multiforme
    Maria Patrizia Mongiardi, Mauro Savino, Maria Laura Falchetti, Barbara Illi, Francesca Bozzo, Cristiana Valle, Manuela Helmer‐Citterich, Fabrizio Ferrè, Sergio Nasi, Andrea Levi · 2016 · Oncotarget
54. Lactylation in cancer biology: Unlocking new avenues for research and therapy
    Xiaoyu Hou, Zhenya Hong, Huimin Zeng, Changyi Zhang, Peng Zhang, Ding Ma, Zhiqiang Han · 2025 · 癌症：英文版
55. Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies
    Shuying Xiao, Suhang Zhang, Kai Sun, Qibo Huang, Qilin Li, Chuanyu Hu · 2025 · Biomarker Research
56. Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells
    Muhammad Mushtaq, Suhas Deoram Darekar, George Klein, Elena Kashuba · 2015 · PLoS ONE
57. Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
    Mauro Corrado, Luca Scorrano, Silvia Campello · 2016 · Oncotarget
58. Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth
    Lixia Chen, Gui‐Yang Xia, Feng Qiu, Chunli Wu, Andria P. Denmon, Xiaolin Zi · 2016 · Scientific Reports
59. Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis
    Wenbin Liu, Xinfang Yu, Li Qun Zhou, Jigang Li, Ming Li, Wei Li, Feng Gao · 2020 · OncoTargets and Therapy
60. Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells
    Mara A. Bonelli, Rita Terenziani, Silvia Zoppi, Claudia Fumarola, Silvia La Monica, Daniele Cretella, Roberta R Alfieri, Andrea Cavazzoni, Graziana Digiacomo, Maricla Galetti et al. · 2020 · International Journal of Molecular Sciences
61. Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis
    Yi Shi, Ze Liu, Qian Zhang, Ingrid Vallee, Zhongying Mo, Shuji Kishi, Xiang‐Lei Yang · 2020 · PLoS Biology
62. Survival of the fittest: metabolic adaptations in cancer
    Marcelo J. Berardi, Valeria R. Fantin · 2010 · Current Opinion in Genetics & Development
63. Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
    Madhura R. Pandkar, Shruti Ganesh Dhamdhere, Sanjeev Shukla · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
64. Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming
    Ping Wang, Jinmei Jin, Xiaohui Liang, Mingzhu Yu, Chun Yang, Fei Huang, Hui Wu, Beibei Zhang, Xiao-yan Fei, Zhengtao Wang et al. · 2021 · Acta Pharmacologica Sinica
65. Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders?
    Aekyong Kim · 2015 · Toxicological Research
66. BMI1 inhibits senescence and enhances the immunomodulatory properties of human mesenchymal stem cells via the direct suppression of MKP-1/DUSP1
    Jin Young Lee, Kyung–Rok Yu, Hyung‐Sik Kim, Insung Kang, Jae-Jun Kim, Byung‐Chul Lee, Soon Won Choi, Ji‐Hee Shin, Yoojin Seo, Kyung‐Sun Kang · 2016 · Aging
67. Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor‐CaMK II‐c‐Myc pathway
    Jianjun Hu, Wenming Duan, Yahua Liu · 2019 · Clinical and Experimental Pharmacology and Physiology
68. The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis
    Liqin Zhao, Nuoya Yu, Yujia Zhai, Yanan Yang, Yixuan Wang, Yue Yang, Zhe Gong, Yanqiu Zhang, Xiaowei Zhang, Weijian Guo · 2024 · Cell Death and Disease
69. PPARγ agonists: Potential treatments for exudative age-related macular degeneration
    Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallée · 2017 · Life Sciences
70. Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines
    Karin Hoppe‐Seyler, Anja Honegger, Felicitas Bossler, Jasmin Sponagel, Julia Bulkescher, Claudia Lohrey, Felix Hoppe‐Seyler · 2017 · Oncotarget
71. A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer
    Jian Huang, Fanglin Tian, Ying Song, Mengru Cao, Shi Yan, Xiuwen Lan, Yimeng Cui, Yaowen Cui, Yue Cui, Dexin Jia et al. · 2021 · Cancer Letters
72. Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma
    Karin Melanie Cabanillas Stanchi, Gernot Bruchelt, Rupert Handgretinger, Ursula Holzer · 2015 · Cancer Biology & Therapy
73. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect
    Luyuan Ma, Wenpeng Liu, An Xu, Quanbo Ji, Yongfu Ma, Yanhong Tai, Yadong Wang, Chuan Shen, Ying Liu, Tao Wang et al. · 2020 · Cancer Science
74. Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
    Kah Ni Tan, Vicky M. Avery, Catalina Carrasco‐Pozo · 2020 · International Journal of Molecular Sciences
75. Proton export upregulates aerobic glycolysis
    Shonagh Russell, Liping Xu, Yoonseok Kam, Dominique F. Abrahams, Daniel Verduzco, Joseph Johnson, Tamir Epstein, Epifanio Ruiz, Mark C. Lloyd, Jonathan Wojtkowiak et al. · 2022 · BMC Biology
76. Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism
    Jilsy M. J. Punnasseril, Abdul Auwal, Vinod Gopalan, Alfred King-yin Lam, Farhadul Islam · 2025 · Cancer Medicine
77. Studying Myc’s Role in Metabolism Regulation
    Anne Le, Chi Van Dang · 2013 · Methods in molecular biology
78. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia
    Yajing Chu, Yangpeng Chen, Mengke Li, Deyang Shi, Bichen Wang, Yu Lian, Xuelian Cheng, Xiaomin Wang, Mingjiang Xu, Tao Cheng et al. · 2019 · Cancer Science
79. Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming
    Yi Dai, Fan Li, Yuwen Jiao, Guoguang Wang, Tian Zhan, Yunwei Xia, Hanyang Liu, Haojun Yang, Jian-Ping Zhang, Liming Tang · 2021 · Cell Death Discovery
80. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth
    Jiin‐Haur Chuang, Ming-Huei Chou, Ming‐Hong Tai, Tsu‐Kung Lin, Chia‐Wei Liou, Ting‐Ya Chen, Wen‐Ming Hsu, Pei‐Wen Wang · 2013 · The International Journal of Biochemistry & Cell Biology
81. Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
    Min Peng, Hui Li, Huấn Cao, Yamei Huang, Weiping Yu, Chuanlai Shen, Jinyang Gu · 2023 · Journal of Gastroenterology
82. Interaction of HIF and USF Signaling Pathways in Human Genes Flanked by Hypoxia-Response Elements and E-box Palindromes
    Junmin Hu, Daniel P. Stiehl, Claudia Setzer, Daniela Wichmann, Dheeraj A. Shinde, Hubert Rehrauer, Pavel Hradecky, Max Gassmann, Thomas A. Gorr · 2011 · Molecular Cancer Research
83. Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1α signaling under hypoxia
    Hengliang Shi, Bao Zheng, Yuxuan Wu, Yuan Tang, Lei Wang, Yong Gao, HUI GONG, Jin Tong Du, Rutong Yu · 2014 · Oncology Reports
84. Understanding complexity in the HIF signaling pathway using systems biology and mathematical modeling
    Zsolt Fábián, Cormac T. Taylor, Lan K. Nguyen · 2016 · Journal of Molecular Medicine
85. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells
    Chunyang Wang, Weiyang Tao, Shaobin Ni, Qi-Yin Chen · 2019 · International Journal of Biological Sciences
86. Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells
    Jun Wang, Xi Liu, Yuanfeng Huang, Pan Li, Minqiang Yang, Shanshan Zeng, Danyang Chen, Qian Wang, Hao Liu, Kai Luo et al. · 2022 · Cell Death Discovery
87. Metabolic switch in cancer – Survival of the fittest
    Hans Raskov, Shruti Gaggar, Asma Tajik, Adile Orhan, Ismail Gögenür · 2022 · European Journal of Cancer
88. Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer
    Mohanraj Gopikrishnan, Hephzibah Cathryn R, Gnanasambandan Ramanathan, Hossam M. Ashour, Gianfranco Pintus, Mohamed Hammad, Manoj Kumar Kashyap, C. George Priya Doss, Hatem Zayed · 2023 · Functional & Integrative Genomics
89. Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis
    Daniel R. Carter, Selina K. Sutton, Marina Pajic, Jayne E. Murray, Eric Owusu Sekyere, Jamie I. Fletcher, Anneleen Beckers, Katleen De Preter, Frank Speleman, Rani E. George et al. · 2016 · Molecular Oncology
90. Non-Hodgkin Lymphoma Metabolism
    Brian James Kirsch, Shu‐Jyuan Chang, Anne Le · 2018 · Advances in experimental medicine and biology
91. Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma
    Erhu Fang, Jianqun Wang, Mei Hong, Liduan Zheng, Qiangsong Tong · 2018 · Biochemical and Biophysical Research Communications
92. Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells
    Dong Jun Kim, Mai‐Tram Vo, Seong Hee Choi, Ji-Heon Lee, So Yeon Jeong, Chung Hwan Hong, Jong Soo Kim, Unn Hwa Lee, Hyung‐Min Chung, Byung Ju Lee et al. · 2019 · Molecular Biology of the Cell
93. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy
    Ching‐Feng Chiu, Jonathan Jaime G. Guerrero, Ric Ryan H. Regalado, Jiayan Zhou, Kin Israel Notarte, Yuwei Lu, Paolo C. Encarnacion, Cidne Carles, Edrian M. Octavo, Dan Christopher I. Limbaroc et al. · 2024 · Cancers
94. Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis via p38 Pathway
    Qi Tan, Limin Duan, Qi Huang, Wenjuan Chen, Zimo Yang, Jiangbin Chen, Yang Jin · 2021 · Journal of Inflammation Research
95. Multiomics analysis couples mRNA turnover and translational control of glutamine metabolism to the differentiation of the activated CD4+ T cell
    Louise S. Matheson, Georg Petkau, Beatriz Sáenz‐Narciso, Vanessa D’Angeli, Jessica McHugh, Rebecca Newman, Haydn Munford, James A. West, Krishnendu Chakraborty, Jennie Roberts et al. · 2022 · Scientific Reports
96. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma
    Jun Liu, Kevin Park, Ziyang Shen, Hannah M. Lee, Purnima Geetha, Mohammadreza Pakyari, Li Chai · 2023 · Frontiers in Immunology
97. New Insights into the Mechanisms of Embryonic Stem Cell Self-Renewal under Hypoxia: A Multifactorial Analysis Approach
    Hélder S. C. Barbosa, Tiago G. Fernandes, Tiago P. Dias, Maria Margarida Diogo, Joaquim M. S. Cabral · 2012 · PLoS ONE
98. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
    Tomohiro Aoki, Kazuyuki Shimada, Akihiko Sakamoto, Keiki Sugimoto, Takanobu Morishita, Yuki Kojima, Satoko Shimada, Seiichi X. Kato, Chisako Iriyama, Shunsuke Kuno et al. · 2016 · Oncotarget
99. Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets
    Yumei Geng, Yu Hu, Fang Zhang, Yajun Tuo, Ri‐Li Ge, Zhenzhong Bai · 2023 · Frontiers in Physiology
100. Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma.
     Yaqing Li, Ruixia Huang, Xiaoli Li, Xiaoran Li, Dandan Yu, Mingzhi Zhang, Jianguo Wen, Mariusz Adam Goscinski, Claes Goran Trope, Jahn Martin Nesland et al. · 2016 · PubMed Central